Zooming in on dendritic cells for CD40 agonists
- PMID: 35352058
- DOI: 10.1038/s43018-022-00340-x
Zooming in on dendritic cells for CD40 agonists
Comment on
-
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting.Nat Cancer. 2022 Mar;3(3):287-302. doi: 10.1038/s43018-022-00329-6. Epub 2022 Feb 21. Nat Cancer. 2022. PMID: 35190724
References
-
- Remer, M., White, A., Glennie, M., Al‐Shamkhani, A. & Johnson, P. Curr. Top Microbiol. Immunol. 405, 165–207 (2017). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials